Race against time: new strategy to save brain function during stroke transfers
NCT ID NCT07253181
Summary
This study is testing whether giving a clot-busting medication called Tenecteplase to stroke patients at their first hospital, before transferring them to a specialized center for advanced treatment, leads to better recovery. The trial involves 572 adults who have had a major stroke caused by a blocked brain artery and arrive at the hospital 4.5 to 24 hours after symptoms start. Researchers will compare outcomes for patients who receive the drug before transfer against those who receive standard care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Shandong Second Medical University
RECRUITINGWeifang, Shandong, 261031, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Xuanwu Hospital Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100053, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.